Jahn, U., Ilan, E., Sandström, M., Lubberink, M., Garske-Román, U., & Sundin, A. (2021). Peptide Receptor Radionuclide Therapy (PRRT) with (177)Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms. Cancers (Basel).

Jahn, Ulrika, Ezgi Ilan, Mattias Sandström, Mark Lubberink, Ulrike Garske-Román, và Anders Sundin. "Peptide Receptor Radionuclide Therapy (PRRT) With (177)Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms." Cancers (Basel) 2021.

Jahn, Ulrika, et al. "Peptide Receptor Radionuclide Therapy (PRRT) With (177)Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms." Cancers (Basel) 2021.